Kynurenine Concentrations During Pregnancy in Women With or Without Chronic Kidney Disease - A Prospective Multicenter Study
Concentrations of Kynurenine During Pregnancy in Women With or Without Chronic Kidney Disease: A Prospective Multicenter Study
Promoteur : CHU de Reims
Titre et résumé fournis en anglais par le registre source, reproduits sans traduction ni interprétation.
Chronic kidney disease (CKD) affects more than 10% of the population worldwide and represents the second most important risk factor for preeclampsia, a life-threatening complication of pregnancy responsible for approximately 80,000 maternal and 500,000 perinatal deaths each year. Experimental studies have suggested a causal link between CKD, relative kynurenine deficiency during pregnancy, and preeclampsia development. Kynurenine, a tryptophan metabolite, plays a central role at the materno-fetal interface, supporting placental energy production, maternal-fetal immune tolerance, and placental perfusion. This study will prospectively assess and compare longitudinal kynurenine concentrations in pregnant women with and without CKD, and evaluate their associations with maternal and fetal outcomes.
Vous quittez essai-clinique.com pour le site externe clinicaltrials.gov, géré par l’organisme responsable de l’annonce. La candidature, les questions d’éligibilité et toute information médicale se traitent uniquement là-bas.
Important
essai-clinique.com ne recueille pas de candidature et ne détermine pas votre éligibilité. Ne transmettez aucune information médicale au site.
Les critères affichés sont une synthèse des informations disponibles. Seul l’organisme responsable de l’étude peut confirmer l’éligibilité d’une personne.